insights_auto
Why is YP2 down 8,13%?
Dive Deeperchevron_right
YP2:FRA
BioLine RX Ltd - ADR
1,47 €
arrow_downward
-8,12%(-0,13) 1D
5-ноя., 22:00:00 GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for YP2...
Open
1,41 €
High
1,55 €
Low
1,41 €
Mkt. cap
9,00 млн
Avg. vol.
25,00
Volume
0,00
52-wk high
3,26 €
52-wk low
1,41 €
No. of employees
22
Open
1,41 €
High
1,55 €
Low
1,41 €
Mkt. cap
9,00 млн
Avg. vol.
25,00
Volume
0,00
52-wk high
3,26 €
52-wk low
1,41 €
No. of employees
22
News stories
From web sources and news partners
Quantisnow
·
27 мүнөт мурун
TransUnion Appoints David Gilbert as Interim Chief Financial Officer
FinancialContent
·
46 мүнөт мурун
FinancialContent - Kratos (NASDAQ:KTOS) posts Q3 2026 sales in line with estimates, quarterly revenue guidance slightly exceeds expectations
Seeking Alpha
·
40 мүнөт мурун
3 things to look out for on Friday (SP500:)
Fox Business
·
1 саат мурун
Stocks plunge as Dem midterm sweep fuels AI regulatory concerns
Profile
BioLineRx Ltd., or BioLine, is a publicly traded drug development company. Headquartered in Israel, its shares are traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange. Wikipedia
About BioLine RX Ltd - ADR
CEOPhilip A. Serlin
Employees22
Founded2003
Headquarters-
SectorHealth Care
Industry-
Websitebiolinerx.com